Co-Diagnostics, Inc. Payment of Financing and Stock Issuance Costs
Co-Diagnostics, Inc. (CODX) reported Payment of Financing and Stock Issuance Costs of $153.84 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentOfFinancingAndStockIssuanceCosts · last filed 2019-04-01
- Co-Diagnostics, Inc. payment of financing and stock issuance costs for fiscal 2018 was $153.84K.
| Period end | Payment of Financing and Stock Issuance Costs 12 month |
|---|---|
| 2018-12-31 | $153.84K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |